SQUAMOUS CELL CARCINOMA OF THE LUNG
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new treatment called BOXR1030 for people with advanced solid tumors that have a specific marker (GPC3). The treatment uses specially designed immune cells given after chemotherapy to help fight the cancer. The main goals are to check safety and find…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LUNG
Phase: PHASE1, PHASE2 • Sponsor: Sotio Biotech Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Simple blood tests could help monitor cancer treatment progress
Knowledge-focused OngoingThis study is collecting blood samples from 102 patients with non-small cell lung cancer, colorectal cancer, or pancreatic cancer who are receiving standard treatments. Researchers will analyze the blood for cancer DNA (ctDNA) to see how it changes over time and whether it relate…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LUNG
Phase: NA • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC